EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2023.9881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Zhenchi Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Nomograms, SEER Program. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-urothelial carcinoma of the bladder (NUCB) is a relatively rare condition, with limited comprehensive studies conducted to date. This research aims to establish nomograms for forecasting overall survival (OS) and cancer-specific survival (CSS) in NUCB patients. It utilizes data of 2,522 patients from the Surveillance, Epidemiology, and End Results (SEER) database spanning from 2004 to 2015. The effectiveness of these nomograms was assessed using receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA). Key independent predictors for OS included age, race, marital status, histological variants, grade, T stage, N stage, M stage, radical cystectomy and chemotherapy administration. For CSS, the predictors were similar, encompassing age, sex, marital status, histological variants, grade, T stage, N stage, M stage, radical cystectomy and chemotherapy. The nomograms showed strong predictive accuracy. In the training cohort, the area under the curve (AUC) values were 0.796 (OS) and 0.799 (CSS) at 1-year, 0.807 (OS) and 0.824 (CSS) at 3-year, and 0.807 (OS) and 0.827 (CSS) at 5-year intervals. In the validation cohort, AUC values were 0.798 (OS) and 0.798 (CSS) at 1-year, 0.810 (OS) and 0.826 (CSS) at 3-year, and 0.811 (OS) and 0.825 (CSS) at 5-year intervals, consistently around 0.8. Calibration curves indicated high congruence between predicted and actual probabilities of OS and CSS, while DCA demonstrated the models' substantial clinical utility. Overall, this study successfully developed and validated prognostic nomograms for NUCB, capable of accurately predicting OS and CSS at 1-, 3-, and 5-years, thereby offering valuable support in clinical decision-making and the design of clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNomogramsSEER ProgramHumansMaleFemaleMiddle AgedAgedROC CurveCystectomyAdultNeoplasm StagingPrognosisAged, 80 and over

Autor:innen und Institutionen

  • Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, Liaoning, China.
  • Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, China.
  • Department of Anesthesiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, China.

Zitieren

APA

Li, Z., Xu, Z., Wang, J., & Wang, M. (2024). Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9881

Vancouver

Li Z, Xu Z, Wang J, Wang M. Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2023.9881

BibTeX
@article{Li2024,
  author = {Li, Zhenchi and Xu, Zhibin and Wang, Jiangping and Wang, Mei},
  title = {Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2023.9881}
}
Kostenlos starten →